We are live on ! Find out more
PHS

PFM Health Sciences Portfolio holdings

AUM $1.1B
1-Year Est. Return 57.92%
This Fund
S&P 500
This Quarter Est. Return
+11%
1 Year Est. Return
+57.92%
3 Year Est. Return
+183.93%
5 Year Est. Return
+283%
10 Year Est. Return
+2,507.28%
AUM
$6.83B
AUM Growth
+$439M
Cap. Flow
-$277M
Cap. Flow %
-4.05%
Top 10 Hldgs %
26.62%
Holding
140
New
27
Increased
39
Reduced
39
Closed
23

Top Buys

Rank Stock Value
1
AGN
Allergan plc
AGN
+$127M
2
ANAB icon
AnaptysBio
ANAB
+$76M
3
ARNA
Arena Pharmaceuticals Inc
ARNA
+$62.1M
4
TSM icon
TSMC
TSM
+$59.5M
5
LKQ icon
LKQ Corp
LKQ
+$45.9M

Top Sells

Rank Stock Value
1
BIDU icon
Baidu
BIDU
+$89.2M
2
CNC icon
Centene
CNC
+$80.2M
3
HOLX
Hologic
HOLX
+$75.2M
4
ECYT
Endocyte, Inc. Common Stock
ECYT
+$65.8M
5
BAX icon
Baxter International
BAX
+$63.9M

Sector Composition

Rank Sector Weight
1 Healthcare 49.61%
2 Technology 13.09%
3 Communication Services 5.22%
4 Consumer Discretionary 2.37%
5 Financials 1.59%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CI icon
1
CALL
Cigna
CI
$76.8B
$294M 4.31%
+1,412,200
New +$262M
IHI icon
2
PUT
iShares US Medical Devices ETF
IHI
$3B
$280M 4.11%
+7,398,000
New +$263M
IWM icon
3
PUT
iShares Russell 2000 ETF
IWM
$82.4B
$230M 3.37%
1,364,800
+125,500
+10% +$21.2M
VTRS icon
4
Viatris
VTRS
$20.5B
$172M 2.52%
4,692,968
+212,248
+5% +$7.97M
JAZZ icon
5
Jazz Pharmaceuticals
JAZZ
$15.3B
$161M 2.36%
958,025
-280,881
-23% -$48.3M
ELV icon
6
Elevance Health
ELV
$82.9B
$146M 2.13%
531,690
-175,554
-25% -$45.6M
AERI
7
DELISTED
Aerie Pharmaceuticals
AERI
$139M 2.04%
2,258,443
-461,775
-17% -$29.7M
PCRX icon
8
Pacira BioSciences
PCRX
$997M
$138M 2.01%
2,797,574
-312,639
-10% -$13.5M
AGN
9
DELISTED
Allergan plc
AGN
$131M 1.93%
+689,949
New +$127M
ARNA
10
DELISTED
Arena Pharmaceuticals Inc
ARNA
$126M 1.84%
2,729,555
+1,532,664
+128% +$62.1M
PTLA
11
DELISTED
Portola Pharmaceuticals, Inc.
PTLA
$123M 1.8%
4,600,847
-478,923
-9% -$15.6M
MYOK
12
DELISTED
MyoKardia, Inc. Common Stock
MYOK
$123M 1.79%
1,878,909
+59,594
+3% +$3.5M
HUM icon
13
Humana
HUM
$47.8B
$115M 1.69%
341,010
+31,909
+10% +$10.4M
BPMC
14
DELISTED
Blueprint Medicines
BPMC
$112M 1.65%
1,440,038
+595,957
+71% +$41.4M
PEN icon
15
Penumbra
PEN
$12.5B
$109M 1.59%
725,401
+151,001
+26% +$21.2M
DVA icon
16
DaVita
DVA
$15B
$107M 1.57%
1,491,826
+206,826
+16% +$14.6M
GOOGL icon
17
Alphabet (Google) Class A
GOOGL
$4.24T
$107M 1.56%
1,768,420
-27,060
-2% -$1.64M
ANAB icon
18
AnaptysBio
ANAB
$1.59B
$105M 1.54%
1,054,361
+916,023
+662% +$76M
ZBH icon
19
Zimmer Biomet
ZBH
$17.4B
$100M 1.47%
784,792
-136,662
-15% -$16.2M
THC icon
20
Tenet Healthcare
THC
$16.7B
$96.1M 1.41%
3,375,241
-961,705
-22% -$31.8M
GDDY icon
21
GoDaddy
GDDY
$12.2B
$93M 1.36%
1,115,201
+139,782
+14% +$10.9M
INTU icon
22
Intuit
INTU
$79.3B
$91.8M 1.34%
403,592
+105,006
+35% +$22.6M
EW icon
23
Edwards Lifesciences
EW
$48.9B
$91M 1.33%
1,568,016
+58,281
+4% +$2.85M
ABT icon
24
Abbott
ABT
$174B
$90M 1.32%
1,227,060
-110,228
-8% -$7.24M
A icon
25
Agilent Technologies
A
$37.5B
$88M 1.29%
1,247,899
+134,830
+12% +$8.92M
1
2 3 4 5

Similar funds

DAM
Delta Asset Management Memphis, Tennessee $1.1B AUM 14.89% 1-Year Est. Return
MAM
Mark Asset Management New York $1.1B AUM 43.79% 1-Year Est. Return
CPRC
Consolidated Portfolio Review Corp Woodbury, New York $1.1B AUM 8.96% 1-Year Est. Return
AWP
Abacus Wealth Partners Santa Monica, California $1.1B AUM 14.74% 1-Year Est. Return
LCM
Legato Capital Management San Francisco, California $1.1B AUM 61.65% 1-Year Est. Return
PRS
Pinkerton Retirement Specialists Coeur D Alene, Idaho $1.1B AUM 30.57% 1-Year Est. Return
DAM
DLD Asset Management New York $1.1B AUM 4.68% 1-Year Est. Return
KCM
Khrom Capital Management Miami Beach, Florida $1.09B AUM 14.82% 1-Year Est. Return

PFM Health Sciences's Q3 2018 Portfolio in Review

As of Q3 2018, PFM Health Sciences held 140 positions worth $6.83B, up 6.9% from $6.39B the previous quarter. Its ten largest holdings account for 27% of the portfolio.

PFM Health Sciences withdrew a net $277M in Q3 2018, closing 23 positions and reducing 39 holdings. Its most notable exit was Baidu, an estimated $89.2M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 50% of assets, up from 49% a quarter earlier, followed by Technology and Communication Services.

Against the trend, PFM Health Sciences opened a new position in Allergan plc worth $131M.

  • PFM Health Sciences's largest Q3 2018 buy was Allergan plc: 689,949 shares worth $131M.
  • PFM Health Sciences added most to AnaptysBio in Q3 2018, an estimated $76M increase.
  • PFM Health Sciences's biggest Q3 2018 reduction was Endocyte, Inc. Common Stock, cutting an estimated $65.8M.
  • PFM Health Sciences fully exited Baidu in Q3 2018, selling an estimated $89.2M.
  • PFM Health Sciences's ten largest holdings make up 27% of its $6.83B portfolio in Q3 2018.
  • PFM Health Sciences opened 27 new positions and closed 23 in Q3 2018.
  • PFM Health Sciences's portfolio value rose 6.9% quarter-over-quarter to $6.83B.

Based on PFM Health Sciences's 13F filing for Q3 2018, filed 13 Nov 2018.